Octavio Servitje Bedate

Senior lecturer

Knowledge area: Dermatologia

Grup d'Educació i d'Avaluació de la Competència Clínica a Bellvitge (COMBELL)

Contact Information
Department of Clinical Sciences
Servei de Dermatologia. Hospital Universitari de Bellvitge. Feixa Llarga s/n.
933359011
oservitje(a)bellvitgehospital.cat

Teaching imparted (current)

Medicina Bucal - Odontología - Universidad de Barcelona.

DERMATOLOGIA - Medicina - Universidad de Barcelona.

More Information: CV Prof Octavio Servitje (https://webgrec.ub.edu/llistats/CU/CU02/02547_900007_202203091056020.html)

Academic training

Medicina y Cirugía . Universidad de Barcelona . 15/02/1984 . (Diploma / Degree / Activities)

Dipl. en Leprología . Universidad de Valencia . 1986 . (Diploma / Degree / Activities)

Médico Especialista en Dermatología Médico Quirúrgica y Venereologia . Hospital Universitario de Bellvitge. Ministerio de Educación Y Ciencia . 26/10/1988 . (Diploma / Degree / Activities)

Doctor en Medicina y Cirurgía . Universidad de Barcelona . 24/12/1993 . (Ph.D.)

Professional experience

Director Limfomes Cutanis. Unitat Funcional de Limfomes. Institut Català d'Oncologia/ Hospital de Bellvitge. Barcelona. 2009

Professor Agregat Temps Complet (plaça vinculada). Departament de Ciències Clíniques. Universitat de Barcelona. 2015

Research interests

Epidemiologia i factors pronòstics en limfomes cutànis

Tècniques de biologia mol. lecular aplicades al diagnòstic i pronòstic dels limfomes cutànis

Epigenètica als limfomes cutanis primaris de cel lules T

Papiloma virus a la patogènia del les lesions premalignes de la mucosa oral

Research Projects

ESTUDIO EN FASE III SOBRE LENALIDOMIDA COMO MANTENIMIENTO TRAS CITORREDUCCIÓN CON GEMCITABINA O DOXORRUBICINA LIPOSÓMICA +/- RADIOTERAPIA EN PACIENTES CON LINFOMA CUTÁNEO DE CÉLULAS T AVANZADO NO TRATADO PREVIAMENTE CON QUIMIOTERAPIA INTRAVENOSA . 2010 - 2016 . Ref.21081 . European organization for the research and treatment of Cancer. (EORTC) . PI: Octavio Servitje Bedate

Ensayo clínico de fase II, multicéntrico y con un único grupo de Pimecrolimus Tópico en Micosis Fungoide estadio Ia-IIa. (Estudio PimTo-MF) . 2014 - 2016 . Ref.PimTo-MF-2014 Nº EudraCT: . Hospital universitario 12 de octubre . PI: Octavio Servitje Bedate

Cutaneous Lymphoma International Consortium PROCLIPI Study: A Multicentre International Observational Prospective Study For The Identification Of Prognostic Factors In Patients With Mycosis Fungoides/Sezary Syndrome: Proposal For An International Prognostic Index For Cutaneous Lymphoma . 2015 - 2020 . Ref.E019 . Cutaneous Lymphoma International Consortium (CLIC) . PI: Octavi Servitje

Red Temática de Investigación Cooperativa en Cáncer (RTICC) . 2013 - 2016 . Ref.RD12/0036/0029 . Ministerio de Economia y Competitividad . PI: Juan Gil Santano

REAL WORLD TREATMENT PATTERNS AND OUTCOMES IN RELAPSED/REFRACTORY CUTANEOUS T-CELL LYMPHOMA FOLLOWING SYSTMIC THERAPY IN ITALY AND SPAIN: A CHART REVIEW STUDY . 2018 - 2020 . Ref.TAK-QUI-2017-01 . TAKEDA PHARMACEUTICALS INTERNATIONAL AG . PI: Octavio Servitje Bedate

Journal Publications

Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R. (2019). The PROCLIPI international registry of early stage Mycosis Fungoides identifies substantial diagnostic delay in most patients. British Journal of Dermatology, 181(2), pp. 350 - 357 . https://doi.org/10.1111/bjd.17258 . ISSN: 0007-0963

Cabello, I.; Alia, P.; Pintó, X.; Muniesa,C.; Fernandez-de-Misa, R.; Peñate, Y.; Morillo, M.; Perez-Farriols, A.; Estrach, T.; Izu, R.; Gallardo, F.; Román, C.; Cervigón,I.; Ortiz-Brugues, A.; Ortiz-Romero, P.L.; Servitje, O. (2018). Association of APOA5 and APOC3 genetic polymorphisms with severity of hypertriglyceridemia in patients with cutaneous T-Cell lymphoma treated with bexarotene. JAMA Dermatology, 154(12), pp. 1424 - 1431 . Institutional Repository . ISSN: 2168-6068

Servitje O; Climent F; Colomo L; Ruiz N; García-Herrera A; Gallardo F; Mercadal S; Pomares H; Muniesa C; Martin-Callizo C; Marcoval J; Rovira R; Estrach T; Pujol RM. (2019). Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression. Journal of Cutaneous Pathology, 46, pp. 182 - 189 . https://doi.org/10.1111/cup.13399 . ISSN: 0303-6987

Gómez-Armayones, S.; Chimenos-Küstner, E.; Marí, A.; Tous, S.; Penín, R.; Clavero, O.; Quirós, B.; Pavón, M.A.; Taberna, M.; Alemany, L.; Servitje, O.; Mena, M. (2019). Human papillomavirus in premalignant oral lesions: no evidence of association in a Spanish cohort. PLoS One, 14(1), p. e0210070 . Institutional Repository . ISSN: 1932-6203

Fernández-de-Misa, R.; Hernández-Machín, B.; Combalía, A.; García-Muret, M.P.; Servitje, O.; Muniesa, C.; Gallardo, F.; Pujol, R.M.; Martí, R.M.; Ortiz-Brugués, A.; Maroñas-Jiménez, L.;Ortiz-Romero, P.L.; Blanch-Rius, L.; Izu, R.; Román, C.; Cañueto, J.; Blanes, M.; Morillo, M.; Bastida, J.;Peñate, Y.; Pérez-Gala, S.; Espinosa-Lara, P.; Pérez-Gil, A.; Estrach, T. (2019). Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma. A multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma. Journal of the European Academy of Dermatology and Venereology, 34(4), pp. 762 - 768 . https://doi.org/10.1111/jdv.16006 . ISSN: 0926-9959

Muniesa C ;Domingo-Domenech E ;Fornons-Servent R ;Peñate Y ;Estrach MT, Ramón MD;Medina S; Flórez Á ;Ortiz-Romero PL; Sánchez-Caminero MP ;Torres-Navarro I; Acebo E ;Yanguas I;Fernández-de-Misa R;Blanes M;Zayas A;Descalzo MA;Garcia-Doval I;Servitje O. (2020). Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry. Journal of the American Academy of Dermatology, 83(5), pp. 1535 - 1538 . https://doi.org/10.1016/j.jaad.2020.07.028 . ISSN: 0190-9622

Quaglino P; Prince HM; Cowan R; Vermeer M;Papadavid L; Bagot M;Servitjie O;Berti E; Guenova E;Stadler R; Querfeld C; Busschots AM; Hodak E; Patsatsi A; Sanches J; Maule M;Yoo J;Kevin M; Fava P;Ribero S;Zocchi L; Rubatto M; Fierro MT;Wehkamp U;Marshalko M;Mitteldorf C; Akilov O; Ortiz-Romero ; Estrach T;Vakeva L; Enz PA;Wobser M; Bayne M;Jonak C;Rubeta M; Forbes A; Bates A;Battistella M;Amel-Kashipaz R ;Vydianath B;Combalia A,;Georgiou E;Hauben E;Hong EK;Jost M;Knobler R; Amitay-Laish I;Miyashiro D ;Cury-Martins J; Martinez X;Muniesa C;Prag-Naveh H,;Nikolaou V;Quint K; Ram-Wolff C; Rieger K;Stranzenbach R; Szepesi Á; Alberti-Violetti S;Felicity E;Cerroni L;Kempf W; Whittaker S; Willemze R; Kim Y,;Scarisbrick JJ. (2021). Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study). British Journal of Dermatology, 184(4), pp. 722 - 730 . https://doi.org/10.1111/bjd.19252 . ISSN: 0007-0963

Gómez-Armayones, S.; Chimenos-Küstner, E.; Arranz C.; Tous, S.; Marquez, S.; Penín, R.M.; Quirós, B.; Taberna, M.; Alemany, L.; Servitje, O.; Mena, M. (2022). Risk factors for oral epithelial dysplasias to become malignant: clinical implications. International Journal of Oral and Maxillofacial Surgery, 51, pp. 473 - 480 . https://doi.org/10.1016/j.ijom.2021.08.012 . ISSN: 0901-5027

Bagot, M.; Hasan, B.; Whittaker, S.; Beylot-Barry, M.; Knobler, R.; Shah, E.; Marreaud, S.; Morris, S.; Dalle, S.; Servitje, O.; Cowan, R9.; Väkevä, L.; Chaby, G.; Jonak, C5.; Fox, C.; Ritchie, D.; Vermeer, MH.; Stadler, R.; Romero, PLO.; Scarisbrick, J.; Quaglino, P. (2017). A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. European Journal of Dermatology, 1;27(3), pp. 286 - 294 . https://doi.org/10.1684/ejd.2017.3008 . ISSN: 1167-1122

Quaglino P.; Maule M.; Prince H.M.; Porcu P.; Horwitz S.; Duvic M.; Talpur R.; Vermeer M.; Bagot M.; Guitart J.; Papadavid E.; Sanches J.A.; Hodak E.; Sugaya M.; Berti E.; Ortiz-Romero P.; Pimpinelli N.; Servitje O.; Pileri A.; Zinzani P.L.; Estrach T.; Knobler R.; Stadler R.; Fierro M.T.; Alberti Violetti S.; Amitay-Laish I.; Antoniou C.; Astrua C.; Chaganti S.; Child F.; Combalia A.; Fabbro S.; Fava P.; Grandi V.; Jonak C.; Martinez-Escala E.; Kheterpal M.; Kim E.J.; McCormack C.; Miyagaki T.; Miyashiro D.; Morris S.; Muniesa C.; Nikolaou V.; Ognibene G.; Onida F.; Osella-Abate S.; Porkert S.; Postigo-Llorente C.; Ram-Wolff C.; Ribero S.; Rogers K.; Sanlorenzo M.; Stranzenbach R.; Spaccarelli N.; Stevens A.; Zugna D.; Rook A.H., Geskin L.J.; Willemze R.; Whittaker S.; Hoppe R.; Scarisbrick J.; Kim Y. (2017). Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Annals of Oncology, 28(10), pp. 1517 - 1525 . https://doi.org/10.1093/annonc/mdx352 . ISSN: 0923-7534